Sotalol

Use in managing life-threatening ventricular arrhythmias

Stephen Winters, L. Enright, J. S. Banas

Research output: Contribution to journalArticle

Abstract

Sotalol, a drug with β-blocking properties that was originally introduced as an antihypertensive agent, is now available for the treatment of life- threatening ventricular arrhythmias. In a trial that enrolled over 2,000 patients, sotalol was compared with imipramine, mexiletine, pirmenol, procainamide, propafenone, and quinidine. Treatment with sotalol was associated with the lowest recurrence of ventricular tachyarrhythmias, overall cardiac mortality, all-cause mortality, and arrhythmic death. Other, smaller, studies also support its use in this setting.

Original languageEnglish (US)
Pages (from-to)33-37
Number of pages5
JournalPrimary Cardiology
Volume20
Issue number5
StatePublished - Jan 1 1994
Externally publishedYes

Fingerprint

Sotalol
Cardiac Arrhythmias
Propafenone
Mexiletine
Procainamide
Quinidine
Mortality
Imipramine
Tachycardia
Antihypertensive Agents
Recurrence
Therapeutics
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Winters, Stephen ; Enright, L. ; Banas, J. S. / Sotalol : Use in managing life-threatening ventricular arrhythmias. In: Primary Cardiology. 1994 ; Vol. 20, No. 5. pp. 33-37.
@article{1641e79db56c44dc94da87c6028afacc,
title = "Sotalol: Use in managing life-threatening ventricular arrhythmias",
abstract = "Sotalol, a drug with β-blocking properties that was originally introduced as an antihypertensive agent, is now available for the treatment of life- threatening ventricular arrhythmias. In a trial that enrolled over 2,000 patients, sotalol was compared with imipramine, mexiletine, pirmenol, procainamide, propafenone, and quinidine. Treatment with sotalol was associated with the lowest recurrence of ventricular tachyarrhythmias, overall cardiac mortality, all-cause mortality, and arrhythmic death. Other, smaller, studies also support its use in this setting.",
author = "Stephen Winters and L. Enright and Banas, {J. S.}",
year = "1994",
month = "1",
day = "1",
language = "English (US)",
volume = "20",
pages = "33--37",
journal = "Primary Cardiology",
issn = "0363-5104",
number = "5",

}

Winters, S, Enright, L & Banas, JS 1994, 'Sotalol: Use in managing life-threatening ventricular arrhythmias', Primary Cardiology, vol. 20, no. 5, pp. 33-37.

Sotalol : Use in managing life-threatening ventricular arrhythmias. / Winters, Stephen; Enright, L.; Banas, J. S.

In: Primary Cardiology, Vol. 20, No. 5, 01.01.1994, p. 33-37.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Sotalol

T2 - Use in managing life-threatening ventricular arrhythmias

AU - Winters, Stephen

AU - Enright, L.

AU - Banas, J. S.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Sotalol, a drug with β-blocking properties that was originally introduced as an antihypertensive agent, is now available for the treatment of life- threatening ventricular arrhythmias. In a trial that enrolled over 2,000 patients, sotalol was compared with imipramine, mexiletine, pirmenol, procainamide, propafenone, and quinidine. Treatment with sotalol was associated with the lowest recurrence of ventricular tachyarrhythmias, overall cardiac mortality, all-cause mortality, and arrhythmic death. Other, smaller, studies also support its use in this setting.

AB - Sotalol, a drug with β-blocking properties that was originally introduced as an antihypertensive agent, is now available for the treatment of life- threatening ventricular arrhythmias. In a trial that enrolled over 2,000 patients, sotalol was compared with imipramine, mexiletine, pirmenol, procainamide, propafenone, and quinidine. Treatment with sotalol was associated with the lowest recurrence of ventricular tachyarrhythmias, overall cardiac mortality, all-cause mortality, and arrhythmic death. Other, smaller, studies also support its use in this setting.

UR - http://www.scopus.com/inward/record.url?scp=0028298354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028298354&partnerID=8YFLogxK

M3 - Article

VL - 20

SP - 33

EP - 37

JO - Primary Cardiology

JF - Primary Cardiology

SN - 0363-5104

IS - 5

ER -